Evidence map›Paper›PMID 37687302›Full record

ArticlePlants (Basel, Switzerland)2023

In Vitro Conversion of

Hugo A Méndez-Hernández, Rosa M Galaz-Ávalos, Ana O Quintana-Escobar, Rodolfo Pech-Hoil, Ana M Collí-Rodríguez, Itzamná Q Salas-Peraza, Víctor M Loyola-Vargas

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Plants (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hugo A Méndez-HernándezPlant Biochemistry and Molecular Biology Unit, Yucatan Scientific Research Center, Street 43, No.130 x 32 y 34, Mérida 97205, Yucatán, Mexico.ORCID 0000-0001-6152-5060
Rosa M Galaz-ÁvalosPlant Biochemistry and Molecular Biology Unit, Yucatan Scientific Research Center, Street 43, No.130 x 32 y 34, Mérida 97205, Yucatán, Mexico.
Ana O Quintana-EscobarPlant Biochemistry and Molecular Biology Unit, Yucatan Scientific Research Center, Street 43, No.130 x 32 y 34, Mérida 97205, Yucatán, Mexico.ORCID 0000-0003-3686-134X
Rodolfo Pech-HoilPlant Biochemistry and Molecular Biology Unit, Yucatan Scientific Research Center, Street 43, No.130 x 32 y 34, Mérida 97205, Yucatán, Mexico.
Ana M Collí-RodríguezYucatan Science and Technology Park, Carretera Sierra Papacal-Chuburna Puerto, Km. 5.5, Sierra Papacal 97302, Yucatán, Mexico.
Itzamná Q Salas-PerazaYucatan Science and Technology Park, Carretera Sierra Papacal-Chuburna Puerto, Km. 5.5, Sierra Papacal 97302, Yucatán, Mexico.
Víctor M Loyola-VargasPlant Biochemistry and Molecular Biology Unit, Yucatan Scientific Research Center, Street 43, No.130 x 32 y 34, Mérida 97205, Yucatán, Mexico.ORCID 0000-0001-5386-4265

Funding

Consejo Nacional de Ciencia y Tecnología México 292474
6 · The paper itself

Abstract

Somatic embryogenesis (SE) is an excellent example of mass plant propagation. Due to its genetic variability and low somaclonal variation, coffee SE has become a model for in vitro propagation of woody species, as well as for large-scale production of vigorous plants that are advantageous to modern agriculture. The success of the large-scale propagation of an embryogenic system is dependent on the development, optimization, and transfer of complementary system technologies. In this study, two successful SE systems were combined with a SETIS™ bioreactor immersion system to develop an efficient and cost-effective approach for the in vitro development of somatic embryos of

Indexed as

acclimatizationbioreactorCoffea arabicaCoffea canephoramicropropagationscale upsomatic embryogenesis

Identifiers

PMID37687302
PMCPMC10490467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.